Epinephrine Injection, Solution
Product Images NDC 51662-1321

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Epinephrine (NDC 51662-1321). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51662-1320-2 Package Labeling (51662 1320 2 Exterior Package Labeling)

Packaging label for Auvi-Q epinephrine injection USP 0.3 mg auto-injector. The label is primarily orange with white text and includes images of two auto-injectors and a trainer device. It indicates the product is for allergic emergencies in patients weighing over 66 lb and contains 2 prefilled auto-injectors plus 1 trainer. The labeler is kaleo, Inc., with storage and usage instructions printed on the back panel.*

FDA Label Image

51662-1321-2 Product Package Labeling (51662 1321 2 Product Package Labeling)

Packaging label for Auvi-Q epinephrine injection USP 0.15 mg auto-injector, intended for allergic emergencies in patients weighing 33 to 66 lb. The carton includes two prefilled auto-injectors and one trainer. Manufactured by kaleo, Inc., with storage instructions and a section for placing the pharmacy patient label.*

FDA Label Image

Serialized Product Labeling (51662 1321 2 Serialized Product Labeling)

Packaging label for Auvi-Q epinephrine injection, USP 0.15 mg auto-injector. The label indicates use for allergic emergencies in patients weighing 33 to 66 pounds and shows that the package contains 2 prefilled auto-injectors and 1 trainer. Distributed by HF Acquisition Co LLC, DBA HealthFirst.*

FDA Label Image

Figure A (A)

Illustration diagram of an epinephrine injection device and its outer case. The device features labeled parts including a speaker, LED lights, viewing window, red safety guard (needle end), and black base. The outer case is shown with two protrusions at the top and an upward-pointing green arrow on the front.*

FDA Label Image

Auvi-q 0.15mg Case (Auvi Q 1321 Label 1)

Label of Auvi-Q epinephrine injection, USP 0.15 mg auto-injector. The label includes instructions to pull the device up from the case for use, storage directions, and a warning to replace the auto-injector if the solution is discolored or contains particles. Manufactured for kaleo, the label is blue with white and yellow text.*

FDA Label Image

Auvi-q 0.15mg Device Label (Auvi Q 1321 Label 2)

Packaging label for Auvi-Q epinephrine injection, USP 0.15 mg auto-injector designed for intramuscular use in allergic emergencies. The label includes step-by-step instructions for use, safety warnings, and disposal information. Manufactured by Kaleo, Inc. and labeled by HF Acquisition Co LLC dba HealthFirst. The label is predominantly blue and white with instructional graphics.*

FDA Label Image

Auvi-q Case Label (Auvi Q Label 1)

Label for Auvi-Q epinephrine injection, USP 0.3 mg auto-injector. The red and orange label includes instructions to pull the device up from the case, states it is for single-use injection and allergic emergencies in patients over 66 lb, and cautions storage at room temperature without refrigeration. Manufactured for Kaleo, with the web address www.auvi-q.com, and origin Germany indicated.*

FDA Label Image

Auvi-q Device Label (Auvi Q Label 2)

Label for Auvi-Q epinephrine injection, USP 0.3 mg auto-injector by Kaléo, indicating use for allergic emergencies. Instructions direct to pull red safety guard, place black end against outer thigh, and push firmly for 2 seconds. Additional cautions include seeking medical attention and proper disposal instructions. Manufactured by Kaléo, Inc., Richmond, VA.*

FDA Label Image

Figure B (B)

Illustration showing hands holding an autoinjector device, demonstrating pressing down and pulling up motions indicated by arrows, likely indicating steps for use or activation of the injection device.*

FDA Label Image

Figure C (C)

An instructional illustration showing a hand holding an epinephrine auto-injector device. The image demonstrates how to push down the device onto the thigh using two downward arrows, indicating activation by pressure. It visually guides correct intramuscular injection technique.*

FDA Label Image

Figure D (D)

An instructional illustration showing a person holding an epinephrine autoinjector against the outer thigh. Next to the figure, a stopwatch indicates holding the injection in place for 2 seconds. This diagram demonstrates the recommended injection technique and timing for intramuscular use.*

FDA Label Image

Figure E (E)

An instructional illustration showing hands pressing down on an injector device over a blue thigh, indicating the proper injection site. To the right is a stopwatch close to 2 seconds, emphasizing the suggested injection duration.*

FDA Label Image

Serialized Label (Serialized 51662 1320 1 Auvi Q 0.3mg)

Auvi-Q epinephrine injection auto-injector, 0.3 mg strength, presented in its red and white protective case. The front label includes instructions to pull the device up from the case, NDC 60842-023-01, and distributor information for HF Acquisition Co., LLC. The packaging highlights use for allergic emergencies in patients over 66 pounds and notes it is for single-use injection.*

FDA Label Image

Serialized 0.15mg (Serialized)

Packaging label of Auvi-Q epinephrine injection USP 0.15 mg auto-injector. The blue and white box indicates it is for single-use injection for allergic emergencies in patients weighing 33 to 66 pounds. Distributed by HF Acquisition Co., LLC, Mukilteo, WA. Label includes a pull instruction to remove the device from the case and notes that instructions are found inside.*

FDA Label Image

Structure (Structure)

Chemical structure of epinephrine, illustrating its molecular framework including a benzene ring with hydroxyl groups and side chains characteristic of the compound.*

FDA Label Image

Serialized 51662-1320-2 (Serialized Product Labeling 51662 1320 2)

Packaging label for Auvi-Q epinephrine injection, USP 0.3 mg auto-injector. The box indicates it contains 2 prefilled auto-injectors plus 1 trainer. The label includes directions for use in allergic emergencies for patients weighing over 66 pounds. Distributed by HF Acquisition Co LLC, DBA HealthFirst.*

FDA Label Image

Trainer Inst. (Trainer Inst)

This is a multi-section instructional text panel titled 'What is the TRAINER for AUVI-Q?'. It explains that the trainer device is needle-free, medicine-free, and reusable for practice injections. The panel includes labeled illustrations comparing the TRAINER (grey casing) and various AUVI-Q auto-injectors (orange, blue, and lavender casings), usage steps with diagrams, and safety notes. It provides detailed guidance on who should practice with the trainer, how to hold and inject using it, and resetting the electronic voice system. The instructions emphasize safe practice for allergic emergencies with AUVI-Q.*

FDA Label Image

Trainer Part 1 (Trainer Part 1)

Packaging label for a TRAINER device for Auvi-Q, used to practice injection technique. The label emphasizes that it contains no active drug or needle, is reusable, and is manufactured for Kaleo with origin Thailand. It instructs users to pull the device up from the case and find use instructions inside the trainer.*

FDA Label Image

Trainer Part 2 (Trainer Part 2)

Packaging label for a Trainer for Auvi-Q, an epinephrine injection trainer for practice only. The label instructs to pull the red safety guard and place the black end against the outer thigh for injection simulation. It states the trainer contains no active drug or needle and includes reset instructions. Manufactured for Kaleo, Richmond, VA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.